Featured Research

from universities, journals, and other organizations

Chronic inflammation: Slowing down immune system when in overdrive

Date:
February 10, 2014
Source:
Garvan Institute of Medical Research
Summary:
Many people suffer from chronic inflammation because their immune systems overreact to 'self' tissue. Scientists believe that a small molecule known as Interleukin 21 is a promising therapeutic target in such cases.

Many people suffer from chronic inflammation because their immune systems overreact to 'self' tissue. Sydney scientists believe that a small molecule known as Interleukin 21 is a promising therapeutic target in such cases.

Related Articles


Interleukin 21 (IL-21) is one of a group of chemical messengers known as 'cytokines', which affect the behavior of immune cells. IL-21 is already well known to play an important role in autoimmune diseases such as Sjφgren's syndrome and type 1 diabetes.

The current study shows how much IL-21 contributes to inflammation. It also shows how important it is to remove IL-21 to reduce inflammation, even where there are other severe immune defects present.

Undertaken at Sydney's Garvan Institute of Medical Research, researchers used mice genetically deficient in another cytokine (IL-2), a well-established mouse model of autoimmunity. In some mice, the IL-21 cell surface receptor was also genetically removed. In these mice, inflammatory disease was much less severe, demonstrating that IL-21 contributes to fatal inflammatory disease.

Immunologists Associate Professor Cecile King and Dr Alexis Vogelzang, in collaboration with bioinformatics experts Drs Marcel Dinger and Brian Gloss, combined cellular analysis and RNA sequencing to compare genes expressed in the disease model with those expressed in healthy immune cells. The study confirmed that IL-21 is one of the most highly expressed genes in autoimmune disease.

The findings are published in the Journal of Immunology, now online.

"RNA sequencing is an unbiased way of determining differential expression of genes, and this data revealed the proinflammatory gene signature of autoimmune disease and confirmed the extent to which IL-21 is elevated in the absence of IL-2," said Associate Professor King.

"When you remove the IL-2 gene, another group of very calming immune cells known as 'T regulatory cells' also disappear -- because T regulatory cells express high levels of the IL-2 receptor and are IL-2 dependent. Without T regulatory cells, the immune system goes haywire and the body starts attacking itself."

"Under these conditions, IL-21 kicks in and make things much worse."

"When IL-21 is blocked, the huge inflammatory response is greatly subdued, although not entirely eliminated."

"There are many people with chronic inflammation caused by defective T cell regulation, and this research suggests that blocking IL-21 with drugs might help them."


Story Source:

The above story is based on materials provided by Garvan Institute of Medical Research. Note: Materials may be edited for content and length.


Journal Reference:

  1. A. Vogelzang, H. M. McGuire, S. M. Liu, B. Gloss, K. Mercado, P. Earls, M. E. Dinger, M. Batten, J. Sprent, C. King. IL-21 Contributes to Fatal Inflammatory Disease in the Absence of Foxp3 T Regulatory Cells. The Journal of Immunology, 2014; 192 (4): 1404 DOI: 10.4049/%u200Bjimmunol.1302285

Cite This Page:

Garvan Institute of Medical Research. "Chronic inflammation: Slowing down immune system when in overdrive." ScienceDaily. ScienceDaily, 10 February 2014. <www.sciencedaily.com/releases/2014/02/140210095406.htm>.
Garvan Institute of Medical Research. (2014, February 10). Chronic inflammation: Slowing down immune system when in overdrive. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2014/02/140210095406.htm
Garvan Institute of Medical Research. "Chronic inflammation: Slowing down immune system when in overdrive." ScienceDaily. www.sciencedaily.com/releases/2014/02/140210095406.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) — Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins